FDA Issues Byetta Warning In Wake Of Deaths
The U.S. Food and Drug Administration has announced that stronger warnings will be added to the label of Amylin Pharmaceuticals Inc.'s Byetta after reports of two deaths linked to the diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article